默沙东完成收购Acceleron Pharma，交易金额达115亿美元
. 默沙东(MRK.US)完成收购Acceleron Pharma(XLRN.US)，交易金额达115亿美元
智通财经APP获悉，默沙东集团 (NYSE:MRK)宣布已成功完成对Acceleron Pharma Inc (NASDAQ:XLRN)的收购。根据协议，默沙东以每股180美元的现金收购Acceleron，总股权价值接近115亿美元。
据悉，Acceleron是一家临床阶段的生物制药公司，专注于抗癌药和针对罕见病的罕见药的研发;目前管线上的产品主要针对呼吸系统和血液学。默沙东此次收购将补充公司的心血管管线，该公司首席执行官Rob Davis表示：“这对我们公司来说是一个重要的战略机遇，可以继续发展我们的心血管产品组合和管线，并进一步加强我们的业务发展战略。”
More Stories
Oil inches higher as Middle East tensions heat up
© Reuters. Army soldier miniatures and stock graph are seen in this illustration taken October 9, 2023. REUTERS/Dado Ruvic/Illustration/File Photo...
Asian stocks rise before US CPI; Japan’s Nikkei extends rally
. JP225 +1.88% Add to/Remove from Watchlist Add to Watchlist Add Position Position added successfully to: + Add another position...
SEC approves spot Bitcoin ETFs
. SEC approves spot bitcoin ETFs BTC/USD +1.76% Add to/Remove from Watchlist Add to Watchlist Add Position Position added successfully...
Google lays off hundreds in Assistant, hardware, engineering teams
© Reuters. The Google logo is seen on the Google house at CES 2024, an annual consumer electronics trade show,...
Amazon has not offered remedies to EU concerns over iRobot deal
© Reuters. FILE PHOTO: The logo of Amazon is seen at the company's logistics centre in Boves, France, October 6,...
Stocks climb as megacaps lead; inflation data, earnings on deck
© Reuters. FILE PHOTO: People walk around the Financial District near the New York Stock Exchange (NYSE) in New York,...